Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$1.09 - $1.66 $2,180 - $3,320
-2,000 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$1.67 - $2.95 $3,340 - $5,900
2,000 New
2,000 $4,000
Q2 2020

Aug 10, 2020

SELL
$2.42 - $3.29 $169,400 - $230,300
-70,000 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$1.5 - $4.59 $105,000 - $321,300
70,000 New
70,000 $202,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.64B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.